PISCATAWAY, N.J., June 9, 2008 -- Sabinsa Corporation today announced that Arumugam Sivakumar, Ph.D., will present "Lactospore: Highlights of a room temperature stable and versatile probiotic" at the Probiotech2008 conference being held June 23-24 in Nantes, France. During his session on June 23, Dr. Sivakumar will discuss the applications and potential benefits of Lactospore(R), Sabinsa’s patented lactic acid bacillus preparation.
Lactospore promotes improved digestion by increasing the amount of enzymes in the stomach and intestines and creating a balance of intestinal flora. It also works to significantly reduce pathogenic bacteria, yeast and parasites, decreasing incidents of diarrhea, constipation and dyspepsia. Lactospore produces the predominantly desired form of L(+) Lactic acid and thus, unlike other probiotics, does not lead to acidosis in the body. In addition, Lactospore does not produce side effects like gas or bloating, as is common with other probiotics. Products containing Lactospore do not need to be refrigerated to retain their maximum potency since the "Bacillus coagulans" microorganisms have been manufactured to retain a relatively strong outer layer that protects against drastic environmental changes. This means the microorganisms are not destroyed when exposed to bile or gastric secretions. Lactospore contains only a "Bacillus coagulans" culture and is preservative-, GMO- and allergen-free as well as certified Kosher. For more information visit www.lactospore.com.
Sabinsa Corporation is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Celebrating its 20th year servicing the natural products industry, Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and wellbeing. Over the past several years, the company has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market.
Sabinsa has six state-of-the-art manufacturing facilities in India dedicated to the production of herbal extracts, phytochemicals, biotech ingredients and supercritical extracts. In the U.S., the company operates a 42,000-square-foot facility in Payson, Utah, which provides cutting-edge capabilities for the development of capsules, tablets, bulk custom pre-mixes, drum-to-hopper blends, stick packs and powdered drinks. All of Sabinsa's facilities use effluent water treatment systems and are environmentally conscious and friendly. All products are intended for human consumption and certified Kosher. For more information visit www.sabinsa.com.
Probiotech2008 provides attendees with updated information on industry applications, scientific research, health claims and regulation issues surrounding probiotics and prebiotics. For more information on this conference visit www.probiotech.eu/2008.
# # #